Brand

Dragon Pharma supplements

Dragon Pharma has 2 products in the NIH Dietary Supplement Label Database (2 labels), 2 of them on the market at its January 2026 release; its labels most often list 5-alpha-hydroxy laxogenin, arimistane, N-acetyl cysteine. It ranks 3,211 of 5,741 brands by products on file.

Products on file
22 labels, sizes and designs counted
On the market
2100% of its products
Labels disclosing no amount
0products whose label gives no amount per ingredient
On file since
2020newest label January 23, 2023

What do Dragon Pharma labels contain?

The ingredients its products list most, with its median amount per serving against the median of every product listing the same ingredient.

Dragon Pharma: most listed ingredients against the market (DSLD version 9.4.0)
IngredientIts productsIts medianMarket median
5-Alpha-Hydroxy Laxogenin1 25 mg25 mg
Arimistane1 37.5 mg45 mg
N-Acetyl Cysteine1 125 mg150 mg
Saw Palmetto1 160 mg200 mg
Tribulus1 250 mg300 mg
Arginine silicate inositol1 0.75 g1.37 g
Beta-Alanine1 3.2 g2 g
Betaine Anhydrous1 2 g1.5 g
Black Pepper1 5 mg5 mg
Caffeine1 425 mg200 mg

Source: Supplement Facts rows of Dragon Pharma's current labels and of every product's, NIH ODS Dietary Supplement Label Database version 9.4.0.

Every Dragon Pharma product

On-market products first, A to Z (page 1 of 1).

When did its products enter the database, and which are still sold?

Dragon Pharma products by the year their current label entered DSLD
YearOn the marketOff the market
202010
202310

Source: NIH Dietary Supplement Label Database label entry dates and market events, version 9.4.0.

Who is behind it?

Its labels most often name Dragon Pharma (manufacturer), on 1 product.

Where next?

How to read a brand's figures, and what labels cannot tell you about a brand: comparing supplement brands by their labels. Label data, not medical advice.